7711-28-6

Basic information

• Product Name: (1-benzyl-1H-benzoimidazol-2-yl)-acetic acid ethyl ester
• Synonyms: (1-benzyl-1H-benzoimidazol-2-yl)-acetic acid ethyl ester
• CAS NO: 7711-28-6
• Molecular Weight: 294.353
• Mol File: 7711-28-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (1-benzyl-1H-benzoimidazol-2-yl)-acetic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (1-benzyl-1H-benzoimidazol-2-yl)-acetic acid ethyl ester(7711-28-6)
• EPA Substance Registry System: (1-benzyl-1H-benzoimidazol-2-yl)-acetic acid ethyl ester(7711-28-6)

Safety Data

• Hazardous Substances Data: 7711-28-6(Hazardous Substances Data)

Upstream product

• 51-17-2 benzoimidazole 
• 4981-92-4 1-benzylbenzimidazole 
• 105-36-2 ethyl bromoacetate 
• 100-39-0 benzyl bromide 

Downstream Products

• 14741-71-0 ethyl (1H-benzimidazol-2-yl)acetate 
• 211103-72-9 4'-cyanomethyl-2-(1-benzylbenzimidazol-2-yl)acetanilide 

Relevant articles and documents

Composition based on benzimidazole carboxylic acid compound and application thereof

The invention belongs to the field of medicine and pharmacology, and particularly relates to a pharmaceutical composition taking benzimidazole carboxylic acid and pharmaceutically acceptable salt thereof as active ingredients. The pharmaceutical composition taking the benzimidazole carboxylic acid and pharmaceutically acceptable salt thereof as main active ingredients is used for preventing and/ortreating respiratory tract reaction and nasal congestion caused by allergic reaction, nasal congestion caused by other reasons and other symptoms, and can realize immediate and/or lasting alleviationof congestion. The invention also provides a method of treating and/or alleviating and/or preventing nasal congestion in a patient, the method comprising administering to a patient in need thereof aneffective amount of the pharmaceutical composition of the benzimidazole carboxylic acid or a pharmaceutically acceptable salt thereof.